CoChat

Low ER+ Breast Cancer

Gloyeske, Nika C., Dabbs, David J., Bhargava, Rohit · 2014 · American Journal of Clinical Pathology

The DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Estrogen receptor (ER) level can be semiquantified by immunohistochemistry (IHC) using the H-score. The score, given as the sum of the percent staining multiplied by the intensity level, ranges from 0 to 300. METHODS: Forty-nine ER+/HER2- invasive tumors with low ER expression (H-scores of 1-100, representing approximately 5% of all tumors) were studied for various morphologic parameters, progesterone receptor (PR), and Ki-67 IHC. RESULTS: Eighteen of 49 patients received neoadjuvant chemotherapy. The morphologic analysis showed that these tumors are often grade 3 and frequently demonstrate a sheet-like growth pattern, an intratumoral lymphocytic inflammatory infiltrate, and necrosis. Eighty percent of tumors showed a Ki-67 proliferation index of more than 50%, and 94% were PR-. Of the 18 patients who received neoadjuvant chemotherapy, six (33%) achieved pathologic complete response. CONCLUSIONS: The low ER+/HER2- cases have morphologic features and a response to the chemotherapy rate that are more similar to triple-negative tumors than the usual type of ER+ tumors.

Overview

Integrity signals

Registry

Crossref · 10.1309/ajcp34cysatwfdpq

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 63

Metadata

Authors
Gloyeske, N. C., Dabbs, D. J., & Bhargava, R.
Affiliations
Magee-Womens Hospital (US)
Venue
American Journal of Clinical Pathology
Published
2014-05-01
Volume
141
Issue
5
Pages
697-701
ISSN
  • 0002-9173 (ISSN-L)
  • 1943-7722
OpenAlex
W2276292796
Cited by
63
References
25
Citations by year
2025: 6 · 2024: 2 · 2023: 13 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 1 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 5
FWCI
1.39
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Clinical Pathology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
ER+/HER2- breast cancer, H-score, tumor morphology, Ki-67 proliferation index, progesterone receptor, neoadjuvant chemotherapy, pathological complete response, triple-negative breast cancer, tumor necrosis
MeSH terms
Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Female, Humans, Immunohistochemistry, Middle Aged, Prognosis, Receptors, Estrogen, Receptors, Progesterone, Biomarkers, Tumor, Erb-b2 Receptor Tyrosine Kinases, Neoadjuvant Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low ER+ Breast Cancer. https://app.cochat.ai/papers/10.1309/ajcp34cysatwfdpq
The paper
Gloyeske, N. C., Dabbs, D. J., & Bhargava, R. (2014). Low ER+ Breast Cancer. American Journal of Clinical Pathology. https://doi.org/10.1309/ajcp34cysatwfdpq

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.